Pfizer

Pfizer and its partner BioNTech today asked the U.S. Food and Drug Administration to allow emergency use of the companies’ new COVID-19 vaccine, which they say has been shown to be safe and 95% effective against the coronavirus in their clinical studies.  The FDA process is expected to take a few weeks, and an advisory committee meeting to review the vaccine is tentatively scheduled for early December. This means the vaccine could […]

Pfizer and BioNTech this week announced early positive results in their ongoing human trials of an experimental COVID-19 vaccine candidate involving 45 test subjects. The companies said people who received two doses of the experimental nucleoside-modified messenger RNA vaccine candidate, BNT162b1, had higher levels of antibodies after 28 days than recovered COVID-19 patients who had […]